A Phase 1 study of an engineered Treg cell therapy, GNTI-122, in adults with recently diagnosed Type 1 Diabetes
Grant Award Details
Grant Type:
Grant Number:
CLIN2-20416
Award Value:
$7,766,382
Status:
Pre-Active
Grant Application Details
Application Title: